| ID | Sequence | Length | GC content |
|---|---|---|---|
| AGAGUUGCACCACUGGGUUUUAUAUUCACUUGGAUCUUUAGUUGUUUUG… | 2851 nt | 0.5244 | |
| AGAGCCUUCGUUUGCCAAGUCGCCUCCAGACCGCAGACAUGAAACUUGU… | 2715 nt | 0.5267 | |
| ACGUGGCCUUCACAGCUGGCCUGAGUGAGCACAGCGGGCACUGAGGGGA… | 3212 nt | 0.5318 | |
| AGAGCCUUCGUUUGCCAAGUCGCCUCCAGACCGCAGACAUGAAACUUGU… | 2721 nt | 0.5270 |
This gene is a member of the transferrin family of genes and its protein product is found in the secondary granules of neutrophils. The protein is a major iron-binding protein in milk and body secretions with an antimicrobial activity, making it an important component of the non-specific immune system. The protein demonstrates a broad spectrum of properties, including regulation of iron homeostasis, host defense against a broad range of microbial infections, anti-inflammatory activity, regulation of cellular growth and differentiation and protection against cancer development and metastasis. Antimicrobial, antiviral, antifungal and antiparasitic activity has been found for this protein and its peptides. Activity against both DNA and RNA viruses has been found, including activity against SARS-CoV-2, and HIV. [provided by RefSeq, Jul 2021]
A study in humans identified the LTF as one of 19 center genes commonly differentially expressed in blood samples from burn patients across early-stage (<11 days), middle-stage (11-49 days), and control groups, indicating its association with burn injury progression [Wu et al. DOI:10.007/s10753-018-0829-0]. Another human study found the LTF was significantly up-regulated (fold change 2.39) in leukocytes from patients with burn sizes >40% total body surface area within one week post-burn, further associating it with this severe injury parameter [Sood et al. DOI:10.0000000000000905].